/PRNewswire/ The "Targeting Pods Market Report 2023-2033" has been added to ResearchAndMarkets.com s offering. World revenue for the Targeting Pods Market.
Pulse Biosciences, Inc. announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter. All patients were successfully.
The Department of Science and Technology (DOST) and the University of Mindanao (UM) officially launched an application that can help local government units in monitoring beneficiaries of the Pantawid Pamilyang Pilipino Program or 4Ps.
Collaboration with CardioNXT provides navigation and mapping system integration with Pulse Biosciences’ nsPFA circumferential catheter to support first-in-human treatments
.